London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Evaluation of postoperative short-term therapy of topical bevacizumab in recurrent pterygium surgery

Poster Details

First Author: W.Nada EGYPT

Co Author(s):    M. Wagieh   M. Al Aswad           

Abstract Details


As corneal vascularization is considered a triggering factor for pterygium recurrence, to gain good patients tolerance and to avoid corneal side effects, the study aimed at evaluation of postoperative short term therapy for 2 weeks of topical bevacizumab in recurrent pterygium surgery


Zagazig university Hospital , Egypt


The study was a prospective comparative one including 40 eyes with recurrent pterygium , all eyes were subjected to pterygium excision with conjunctival autograft , postoperative topical tobramycine and dexamethazone . Among the 40 eyes 20 eyes (group 1)were subjected to addition of postoperative topical bevacizumab 5mg/ml 4 times daily for 2weeks . The remaining 20 eyes were (group 2). Follow up cases for 6 months recording corneal vascularization and recurrence.


The study showed good patients tolerance to topical bevacizumab . Group 1 of topical bevacizumab recorded after 6 months one case recurrence (5%) comparing to group 2 which recorded three cases (15%). Corneal vascularization was less in group 1than group 2.


Postoperative short term therapy of topical bevacizumab carries the safety for the cornea , the good tolerance of patients and minimizing corneal vascularization and hence recurrence in recurrent pterygium surgery. FINANCIAL INTEREST: NONE

Back to Poster listing